Blueprint Adaptive Growth Allocation Fund

Institutional Class


Investor Class


 Current Fund NAV

NAV data as of March 31st, 2023 for Institutional Class (BLUIX). NAV data reflects price of 1 share, as well as price change and percent change since the previous trading day.


4 Primary Attributes:

Global Asset Class Diversification
Exposure across eight major global asset classes in a single investment vehicle

Rules-Based Process
The repeatable process for making all portfolio decisions leaves no room for emotional decision-making during times of euphoria or fear, which seeks to manage risk during times of prolonged market volatility 

Focus on Managing Downside Risk
Portfolio is constructed to manage risk during periods of market downtrends (like the Coronacrash of March 2020), which can be particularly important for those around retirement age

Automatic Adjustments in Response to Market Changes
Portfolio naturally adapts when there are uptrends/downtrends in an asset class, interest rates change, volatility arises, and inflation/deflation occurs


The Result is a Dynamic Portfolio:

If the markets are in a “business as usual” mode, then the portfolio will look similar to other investment strategies your clients may be familiar with.

But, when unique market events arise, the portfolio adjusts.

Here’s what this process can look like during four common market conditions: 

This adaptive approach gives Blueprint the flexibility to manage risk, regardless of the market environment.

Flagship Strategy Since 2013:

The Blueprint Adaptive Growth Allocation Fund replicates the Blueprint Tactical Growth Strategy, which has been the flagship strategy of Blueprint Investment Partners since January 2013.



Institutional BLUIX 90386H420 March 31, 2020 1.45% 1.31%
Investor BLUPX 90386H438 March 31, 2020 7.01% 1.55%


Blueprint Fund Management, LLC (the “Adviser”) has contractually agreed, until June 30, 2024, to reduce Management Fees and reimburse Other Expenses to the extent necessary to limit Total Annual Fund Operating Expenses (excluding brokerage costs, taxes, interest, borrowing costs such as interest and dividend expenses on securities sold short, Acquired Fund Fees and Expenses, costs to organize the Fund, extraordinary expenses such as litigation and merger or reorganization costs and other expenses not incurred in the ordinary course of the Fund’s business) to 1.25% of the Fund’s average daily net assets of its Institutional Class shares and to 1.50% of its Investor Class shares.


Quarterly as of 12/31/2022

Institutional -18.28% -18.28% 4.60%
Investor -18.49% -18.49% 4.32%


Performance data quoted represents past performance, which is no guarantee of future results. Investment return and principal value are historical and may fluctuate so that redemption value may be worth more or less than the original cost. Current performance may be lower or higher than what is quoted. Current performance may be lower or higher than the performance data quoted. Investors may obtain performance data current to the most recent month-end by calling 866-983-4525.

TOP 10 Holdings

Quarterly as of 12/31/2022

Top 10 Individual Equity Holdings


Ticker Holding Weight
UNH United Health Group, Inc. 2.05%
BRK.B Berkshire Hathaway, Inc-B 1.89%
XOM Exxon Mobil Corp 1.85%
JNJ Johnson & Johnson 1.65%
LLY Eli Lilly & Co 1.36%
CVX Chevron Corp. 1.33%
JPM JPMorgan Chase & Co 1.31%
ABBV Abbvie, Inc. 1.31%
MRK Merck & Co, Inc. 1.22%
V Visa, Inc. – Class A 1.16%


Top 10 Overall Holdings


Ticker Holding Weight
OPER ClearShares Ultra-Short 6.39%
BIL SPDR Bloomberg 1-3 Month Bill 6.37%
Cash 5.81%
SHV iShares Short Treasury Bond ETF 4.91%
SGOV iShares 0-3 Month T-Bond 4.90%
IAU iShares Gold Trust 3.12%
TFLO iShares Treasury Floating 3.12%
UNH United Health Group, Inc. 2.05%
LLY SPDR Barclays Intl Treasury ETF 1.94%
BRK.B Berkshire Hathaway, Inc-B 1.89%
Current and future portfolio holdings are subject to risk.


Monthly as of 2/28/2023


Fund holdings are subject to change and should not be considered a recommendation to buy or sell any security.